
LifeVantage Corporation announced it has completed an international study of its MindBody GLP-1 System. The in vitro cell study used Enzyme-Linked Immunosorbent Assay (ELISA) to measure total GLP-1 production and used fluorescent microscopy to visualize outcomes.